MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells

Immunological Investigations

Volumn 37, Issue 3, 2008, Pages 215-225

  Wright, Stephen E ^a,b,c   Rewers Felkins, Kathleen A ^a,b,c   Quinlin, Imelda S ^a,b,c   Fogler, William E ^d   Phillips, Catherine A ^a,b   Townsend, Mary ^e   Robinson, William ^b,c   Philip, Ramila ^f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c Harrington Cancer Center   (United States)

^d ENTREMED INC   (United States)

^e Coffee Memorial Blood Bank ^*  (United States)

^f Immunotope Inc   (United States)

Author keywords

Cell death; Major histocompatibility complex; Mucins human

Indexed keywords

MUCIN 1; PROTEIN ANTIBODY;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, NEOPLASM; ANTIGEN-PRESENTING CELLS; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FEMALE; HUMANS; IMMUNODOMINANT EPITOPES; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MAMMARY NEOPLASMS, ANIMAL; MICE; MUCIN-1; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 41849144085     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130801967874     Document Type: Article

References (24)

1. Ahmed, S. A., Gogal, R.M., Walsh, J.E. (1994). A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J. Immunol. Meth. 170:211-224.
2. Alajez, N. M., Schmielau, J., Alter, M. D., Cascio, M., Finn, O. J. (2005). Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution. Blood 105:4583-4589.
3. Apostolopoulos, V., Karanikas, V., Haurum, J. S., McKenzie, I. F. (1997). Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen. J. Immunol. 159:5211-5218.
4. Barnd, D. L., Lan, M. S., Metzgar, R.S., Finn, O. J. (1989). Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl. Acad. Sci. USA 86:7159-7163.
5. Brossart, P., Heinrich, K. S., Stuhler, G., Behnke, L., Reichardt, V. L., Stevanovic, S., Muhm, A., Rammensee, H. G., Kanz, L., Brugger, W. (1999). Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood 93:4309-4317.
6. Bu, D., Domenech, N., Lewis, J., Taylor-Papadimitriou, J., Finn, O. J. (1993). Recombinant vaccinia mucin vector: in vitro analysis of expression of tumor-associated epitopes for antibody and human cytotoxic T-cell recognition. J. Immunother. 14:127-135.
7. Domenech, N., Henderson, R. A., Finn, O.J. (1995). Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J. Immunol. 155:4766-4774.
8. Finn, O. J. (1992). Antigen-specific, MHC-unrestricted T cells. Biotherapy 4:239-249.
9. Fogler, W.E. (1995). Unpublished Raw Data.
10. Gendler, S. J. (2001). MUC1, the Renaissance molecule. J Mammary Gland Biol. Neoplasia 3:339-353.
11. Gendler, S. J., Lancaster, C. A., Taylor-Papadimitriou, J., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Lalani, E. N., Wilson, D. (1990). Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem. 265:15286-15293.
12. Gendler, S. J., Spicer, A.P., Lalaini, E. N., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Boshell, M., Taylor-Papadimitriou, J. (1991). Structure and biology of a carcinoma-associated mucin, MUC1. Am. Rev. Respir. Dis. 144:S42-S47.
13. Hanisch, F. G., Muller, S. (2000). MUC1: the polymorphic appearance of a human mucin. Glycobiology 10:439-449.
14. Ioannides, C. G., Fisk, B., Jerome, K. R., Irimura, T., Wharton, J. T., Finn, O. J. (1993). Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J. Immunol. 151:3693-3703.
15. Kornbluth, J., Flomenberg, N., Dupont, B. (1982). Cell surface phenotype of a cloned line of natural killer cells. J. Immunol. 129:2831-2837.
16. Orr, M. K., Burnside, J. S., Phillips, C. A., Philip, R., Dombrowski, K. E., Wright, S. E. (2007). MHC-restricted presentation of a single repeat of MUC1 mucin. Immunol. Invest. 36:271-283.
17. Plum, S. M., Hanson, A. D., Volker, K. M., Vu, H. A., Sim, B. K., Fogler, W. E., Fortier, A.H. (2003). Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an othrotopic murine mammary carcinoma model. Clincal Cancer Res. 9:4619-4626.
18. Quinlin, I. S., Burnside, J. S., Dombrowski, K. E., Phillips, C. A., Dolby, N., Wright, S. E. (2007). Context of MUC1 epitope: immunogenicity. Oncol. Rep. 17:453-456.
19. Reddish, M., MacLean, G.D., Koganty, R.R., Kan-Mitchell, J., Jones, V., Mitchell, M.S., Longenecker, B.M. (1998). Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide. Int. J. Cancer 76:817-823.
20. Roehm, N. W., Rodgers, G. H., Hatfield, S. M., Glasebrook, A. L. (1991). An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Meth. 142:257-265.
21. Thiele, D. L., Lipsky, P. E. (1989). The role of cell surface recognition structures in the initiation of MHC-unrestricted 'promiscuous' killing by T cells. Immunol. Today 10:375-381.
22. Visonneau, S.; Cesano, A.; Porter, D. L.; Luger, S. L.; Schuchter, L.; Kamoun, M.; Torosian, M. H.; Duffy, K.; Sickles, C.; Stadtmauer, E. A.; Santoli, D. (2000). Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer. Clin. Cancer. Res. 6:1744-1754.
23. Wright, S. E., Kilinski, L., Talib, S., Lowe, K. E., Burnside, J. S., Wu, J. Y., Dolby, N., Dombrowski, K. E., Lebkowski, J. S., Philip, R. (2000). Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site. J. Immunother. 23:2-10.
24. Wright, S. E., Khaznadar, R., Wang, Z., Quinlin, I. S., Rewers-Felkins, K. A., Phillips, C. A., Patel, S. (2008). Generation of MUC1-stimulated mononuclear cells using optimized conditions. Scand. J. Immunol. 67(1):24-29. Epub 2007 Nov 15.